We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 11.35%
4 Consumer Discretionary 9.79%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYF icon
151
Synchrony
SYF
$24.4B
$40.3M 0.18%
1,716,242
+1,568,700
+1,063% +$42.4M
KSU
152
DELISTED
Kansas City Southern
KSU
$40.2M 0.18%
421,491
-31,550
-7% -$3.2M
AMBA icon
153
Ambarella
AMBA
$3.04B
$39.9M 0.17%
1,140,665
-42,546
-4% -$1.51M
CI icon
154
Cigna
CI
$78.4B
$39.8M 0.17%
209,590
-61,868
-23% -$12.9M
BBY icon
155
Best Buy
BBY
$19B
$39.3M 0.17%
741,290
-7,655
-1% -$500K
CVS icon
156
CVS Health
CVS
$135B
$39.2M 0.17%
598,532
+25,369
+4% +$1.89M
CME icon
157
CME Group
CME
$95.4B
$39.2M 0.17%
208,208
-35,683
-15% -$6.59M
GMED icon
158
Globus Medical
GMED
$11.1B
$39M 0.17%
901,699
-37,133
-4% -$1.85M
COF icon
159
Capital One
COF
$128B
$39M 0.17%
516,257
-13,476
-3% -$1.17M
DD icon
160
DuPont de Nemours
DD
$18.6B
$38.8M 0.17%
286,380
-38,087
-12% -$5.47M
AVB icon
161
AvalonBay Communities
AVB
$27.5B
$38.7M 0.17%
222,626
+40,100
+22% +$7.25M
RTX icon
162
RTX Corp
RTX
$290B
$38.5M 0.17%
574,576
-76,989
-12% -$6.04M
TFC icon
163
Truist Financial
TFC
$63.9B
$38.1M 0.17%
879,344
-739,455
-46% -$35.5M
MDLZ icon
164
Mondelez International
MDLZ
$83.4B
$38M 0.17%
948,914
-185,194
-16% -$7.9M
WU icon
165
Western Union
WU
$2.53B
$38M 0.17%
2,225,598
-122,600
-5% -$2.23M
MRSH
166
Marsh
MRSH
$94.3B
$38M 0.17%
475,865
+26,161
+6% +$2.18M
ATVI
167
DELISTED
Activision Blizzard
ATVI
$37.9M 0.17%
813,942
+47,043
+6% +$2.82M
PFPT
168
DELISTED
Proofpoint, Inc.
PFPT
$37.8M 0.16%
450,726
+97,778
+28% +$9.05M
AMTD
169
DELISTED
TD Ameritrade Holding Corp
AMTD
$37.5M 0.16%
765,616
-25,989
-3% -$1.32M
BFH icon
170
Bread Financial
BFH
$4.32B
$37M 0.16%
308,881
+125,753
+69% +$19.7M
CM icon
171
Canadian Imperial Bank of Commerce
CM
$106B
$36.9M 0.16%
990,714
+16,600
+2% +$706K
AGN
172
DELISTED
Allergan plc
AGN
$36.8M 0.16%
275,502
-127,470
-32% -$20.9M
AMH icon
173
American Homes 4 Rent
AMH
$12.1B
$36.4M 0.16%
1,833,502
+75,661
+4% +$1.55M
VRSK icon
174
Verisk Analytics
VRSK
$27.9B
$36.3M 0.16%
333,268
+88,434
+36% +$10.3M
ZTS icon
175
Zoetis
ZTS
$32.7B
$36.2M 0.16%
423,107
+88,996
+27% +$8.02M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.